Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Baxter
Mallinckrodt
McKinsey
Moodys

Last Updated: September 28, 2022

Investigational Drug Information for d-amphetamine


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the development status for investigational drug d-amphetamine?

d-amphetamine is an investigational drug.

There have been 31 clinical trials for d-amphetamine. The most recent clinical trial was a Phase 3 trial, which was initiated on March 10th 2005.

The most common disease conditions in clinical trials are Cocaine-Related Disorders, Attention Deficit Disorder with Hyperactivity, and Hyperkinesis. The leading clinical trial sponsors are National Institute on Drug Abuse (NIDA), The University of Texas Health Science Center, Houston, and Shire.

Recent Clinical Trials for d-amphetamine
TitleSponsorPhase
[C-11]NPA PET-amphetamine in Cocaine Use DisordersNational Institute on Drug Abuse (NIDA)Early Phase 1
[C-11]NPA PET-amphetamine in Cocaine Use DisordersRajesh NarendranEarly Phase 1
Neurobehavioral Mechanisms of Cocaine ChoiceJoshua A. Lile, Ph.D.Early Phase 1

See all d-amphetamine clinical trials

Clinical Trial Summary for d-amphetamine

Top disease conditions for d-amphetamine
Top clinical trial sponsors for d-amphetamine

See all d-amphetamine clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Baxter
Mallinckrodt
McKinsey
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.